3-Hydroxybutyric Acid is an organic acid in the biochemical class of ketone bodies. Chemically known as beta-hydroxybutyrate (BHB), it is produced in the liver from acetyl-CoA during periods when fatty acid oxidation increases and carbohydrate supply is relatively low. Clinically it has been used as a metabolic indicator for over a century because it reliably reflects ketogenesis and shifts in whole-body fuel use. Biologically, BHB serves as a transportable energy substrate: it circulates in blood, crosses the blood–brain barrier, and is taken up by muscle and brain for oxidation. Levels in urine or saliva rise when production exceeds tissue uptake or renal handling changes, so its measurement links mitochondrial fatty acid oxidation with systemic energy availability and metabolic signaling.

Elevated 3-Hydroxybutyric Acid often indicates an increased reliance on fat-derived fuels and active ketogenesis. Common patterns associated with higher levels include fasting, prolonged exercise, low-carbohydrate intake, or shifts in mitochondrial substrate use; urine concentration can also be affected by hydration and renal excretion. Low or undetectable levels suggest limited ketone production relative to glucose availability, efficient suppression of fatty acid oxidation, or low substrate supply for ketogenesis. Interpretation of high or low values should be done alongside other Cellular Zoomer markers (Krebs intermediates, lactate/pyruvate, oxidative stress indicators, and genetics) to distinguish adaptive metabolic states from persistent substrate or mitochondrial limitations.

On the Cellular Zoomer, 3-Hydroxybutyric Acid evaluates ketone production and fat-derived energy flow as part of a broader mitochondrial and metabolic picture. It complements Krebs cycle, glycolytic, and oxidative stress markers to clarify whether cells are shifting toward fatty acid oxidation or relying on carbohydrate metabolism, supporting more personalized metabolic assessment and monitoring.